By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Genomic Health today said that it has reached an exclusive agreement with Palex Medical to distribute the firm's Oncotype DX breast cancer test in Spain and Portugal.

The Redwood City, Calif.-based pharmacogenomics firm said that the agreement will increase physician and patient access to the test in the European market.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: swapping yeast genes with human orthologs to study conservation of function, and more.

Hong Kong is using DNA phenotyping to shame litterers.

A study appearing in Cell suggests some metastatic castration-resistant prostate cancer patients could benefit from PARP inhibitor therapy.

NIH's Francis Collins writes that scientific advances are poised to help populations all over the world, but more scientists are needed to keep the momentum.